T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STKL
2726
DELISTED
SunOpta
STKL
| $67K | ﹤0.01% |
19,743
-569
| -3% | -$2.85K |
|
|
NSTG
2727
DELISTED
NanoString Technologies, Inc.
NSTG
| $67K | ﹤0.01% |
38,759
+942
| +2% | +$2.87K |
|
2728
Liquidia Corp
LQDA
$7.05B
| $66K | ﹤0.01% |
+10,353
| New | +$74.6K |
|
2729
Fossil Group
FOSL
$311M
| $65K | ﹤0.01% |
31,488
+1,433
| +5% | +$3.34K |
|
|
IAUX
2730
i-80 Gold Corp
IAUX
$1.52B
| $65K | ﹤0.01% |
42,147
+2,971
| +8% | +$5.82K |
|
2731
Telos
TLS
$324M
| $65K | ﹤0.01% |
27,006
| – | – |
|
|
AEVA
2732
Aeva Technologies
AEVA
$1.75B
| $64K | ﹤0.01% |
16,674
| – | – |
|
2733
Willamette Valley Vineyards
WVVI
$11.5M
| $64K | ﹤0.01% |
10,850
| – | – |
|
|
OSG
2734
DELISTED
Overseas Shipholding Group Inc.
OSG
| $64K | ﹤0.01% |
14,506
+2,783
| +24% | +$11.6K |
|
2735
NextNav
NN
$3.25B
| $63K | ﹤0.01% |
12,138
-626
| -5% | -$2.52K |
|
2736
SoundHound AI
SOUN
$3.29B
| $63K | ﹤0.01% |
30,846
+2,468
| +9% | +$6.28K |
|
2737
ThredUp
TDUP
$405M
| $63K | ﹤0.01% |
15,706
+1,876
| +14% | +$6.36K |
|
|
ENZ
2738
DELISTED
Enzo Biochem, Inc.
ENZ
| $63K | ﹤0.01% |
44,800
| – | – |
|
2739
Emergent Biosolutions
EBS
$233M
| $62K | ﹤0.01% |
18,195
-9,495
| -34% | -$52.6K |
|
|
KYNB
2740
Kyntra Bio
KYNB
$28.7M
| $62K | ﹤0.01% |
2,828
+976
| +53% | +$38.3K |
|
2741
FTC Solar
FTCI
$38.8M
| $62K | ﹤0.01% |
4,785
| – | – |
|
|
ME
2742
DELISTED
23andMe Holding Co
ME
| $62K | ﹤0.01% |
3,136
+577
| +23% | +$16.2K |
|
2743
iQIYI
IQ
$1.28B
| $61K | ﹤0.01% |
12,700
| – | – |
|
|
VXRT
2744
DELISTED
Vaxart
VXRT
| $60K | ﹤0.01% |
78,500
| – | – |
|
2745
Dare Bioscience
DARE
$21.6M
| $59K | ﹤0.01% |
10,492
| – | – |
|
2746
Inovio Pharmaceuticals
INO
$79.6M
| $59K | ﹤0.01% |
12,500
+5,708
| +84% | +$31.5K |
|
2747
MaxCyte
MXCT
$136M
| $59K | ﹤0.01% |
18,797
+674
| +4% | +$2.71K |
|
2748
PLAYSTUDIOS Inc
MYPS
$67.3M
| $59K | ﹤0.01% |
18,302
+1,846
| +11% | +$7.32K |
|
2749
PEDEVCO
PED
$150M
| $59K | ﹤0.01% |
2,875
| – | – |
|
2750
Destination XL Group
DXLG
$33M
| $58K | ﹤0.01% |
12,756
+1,273
| +11% | +$5.97K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.